Clinical Trials Directory

Trials / Completed

CompletedNCT01959932

Reduced Exposure Study in Smokers Using THS 2.2 With 5 Days in a Confinement Setting.

A Randomized, Controlled, Open-label, 3-arm Parallel Group, Single-center Study to Demonstrate Reductions in Exposure to Selected Smoke Constituents in Smoking, Healthy Subjects Switching to the Tobacco Heating System 2.2 (THS 2.2) or Smoking Abstinence, Compared to Continuing to Use Conventional Cigarettes, for 5 Days in Confinement.

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
169 (actual)
Sponsor
Philip Morris Products S.A. · Industry
Sex
All
Age
21 Years – 65 Years
Healthy volunteers
Accepted

Summary

The overall goal of the study is to evaluate if the ad libitum use of the Tobacco Heating System 2.2 (THS 2.2) for 5 days by adult healthy smokers results in a reduction in the levels of biomarkers of exposure (BoExp) for selected harmful and potentially harmful constituents (HPHCs) compared to smoking conventional cigarettes (CC) and smoking abstinence (SA).

Conditions

Interventions

TypeNameDescription
OTHERTobacco Heating System (THS 2.2)THS 2.2 ad libitum for 5 days in confinement
OTHERSmoking abstinence (SA)SA for 5 days in confinement
OTHERConventional cigarette (CC)Subject's own preferred brand of CC ad libitum for 5 days in confinement

Timeline

Start date
2013-06-01
Primary completion
2013-09-01
Completion
2014-06-01
First posted
2013-10-10
Last updated
2020-03-12
Results posted
2016-10-13

Locations

1 site across 1 country: Poland

Source: ClinicalTrials.gov record NCT01959932. Inclusion in this directory is not an endorsement.